Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hui-Jie Bian (Huijie Bian)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 21

Top Venues

Signal transduction and targeted therapy

Science (New York, N.Y.)

Oncogene

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jiejie Geng, Xu Yang, Kun Wang, Ke Wang, Ruo Chen, Zhi-Nan Chen, Chuan Qin, Guizhen Wu, You-Chun Wang, Ke Xu, Peng Du, Jiangning Liu, Shirui Chen, Tao Zhang, Xiuxuan Sun, Ting Guo, Ying Shi, Zheng Zhang, Ding Wei, Peng Lin, Qingyi Wang, Jing Yuan, Jiuxin Qu, Jin Zou, Yingxia Liu, Hongzhou Lu, Ping Zhu, Hui-Jie Bian, Liang Chen
Immunological and metabolic characteristics of the Omicron variants infection. Signal transduction and targeted therapy 8 (1) (2023)
Jiejie Geng, Xu Yang, Kun Wang, Ke Wang, Ruo Chen, Zhi-Nan Chen, Chuan Qin, Guizhen Wu, You-Chun Wang, Ke Xu, Peng Du, Jiangning Liu, Shirui Chen, Tao Zhang, Xiuxuan Sun, Ting Guo, Ying Shi, Zheng Zhang, Ding Wei, Peng Lin, Qingyi Wang, Jing Yuan, Jiuxin Qu, Jin Zou, Yingxia Liu, Hongzhou Lu, Ping Zhu, Hui-Jie Bian, Liang Chen
Immunological and metabolic characteristics of the Omicron variants infection. Signal transduction and targeted therapy 8 (1) (2023)
Hui-Jie Bian, Liang Chen, Zhao-Hui Zheng, Xiu-Xuan Sun, Jie-Jie Geng, Ruo Chen, Ke Wang, Xu Yang, Shi-Rui Chen, Si-Yu Chen, Rong-Hua Xie, Kui Zhang, Jin-Lin Miao, Jun-Feng Jia, Hao Tang, Shuang-Shuang Liu, Hong-Wei Shi, Yong Yang, Xiao-Chun Chen, Vinay Malhotra, Kulsoom Bano Mehdi, Iffat Khanum, Faisal Mahmood, Saeed Hamid, Claudio Marcel Berdun Stadnik, Kengi Itinose, Caroline Cândida Carvalho de Oliveira, Cesar Dusilek, Lucas Rivabem, Adilson Joaquim Westheimer Cavalcante, Suzara Souto Lopes, Wladmir Faustino Saporito, Fábio José Concilio Fucci, Jesus Abraham Simon-Campos, Ling Wang, Lin-Na Liu, Qing-Yi Wang, Ding Wei, Zheng Zhang, Zhi-Nan Chen, Ping Zhu
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial. Signal transduction and targeted therapy 8 (1) (2023)
Hui-Jie Bian, Liang Chen, Zhao-Hui Zheng, Xiu-Xuan Sun, Jie-Jie Geng, Ruo Chen, Ke Wang, Xu Yang, Shi-Rui Chen, Si-Yu Chen, Rong-Hua Xie, Kui Zhang, Jin-Lin Miao, Jun-Feng Jia, Hao Tang, Shuang-Shuang Liu, Hong-Wei Shi, Yong Yang, Xiao-Chun Chen, Vinay Malhotra, Kulsoom Bano Mehdi, Iffat Khanum, Faisal Mahmood, Saeed Hamid, Claudio Marcel Berdun Stadnik, Kengi Itinose, Caroline Cândida Carvalho de Oliveira, Cesar Dusilek, Lucas Rivabem, Adilson Joaquim Westheimer Cavalcante, Suzara Souto Lopes, Wladmir Faustino Saporito, Fábio José Concilio Fucci, Jesus Abraham Simon-Campos, Ling Wang, Lin-Na Liu, Qing-Yi Wang, Ding Wei, Zheng Zhang, Zhi-Nan Chen, Ping Zhu
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial. Signal transduction and targeted therapy 8 (1) (2023)
Yue Zhai, Liang Chen, Qian Zhao, Zhao-Hui Zheng, Zhi-Nan Chen, Hui-Jie Bian, Xu Yang, Huan-Yu Lu, Peng Lin, Xi Chen, Ruo Chen, Hao-Yang Sun, Lin-Ni Fan, Kun Zhang, Bin Wang, Xiu-Xuan Sun, Zhuan Feng, Yu-Meng Zhu, Jian-Sheng Zhou, Shi-Rui Chen, Tao Zhang, Si-Yu Chen, Jun-Jie Chen, Kui Zhang, Yan Wang, Yang Chang, Rui Zhang, Bei Zhang, Li-Juan Wang, Xiao-Min Li, Qian He, Xiang-Min Yang, Gang Nan, Rong-Hua Xie, Liu Yang, Jing-Hua Yang, Ping Zhu
Cysteine carboxyethylation generates neoantigens to induce HLA-restricted autoimmunity. Science (New York, N.Y.) 379 (6637) (2023)
Jiejie Geng, Xu Yang, Kun Wang, Ke Wang, Ruo Chen, Zhi-Nan Chen, Chuan Qin, Guizhen Wu, You-Chun Wang, Ke Xu, Peng Du, Jiangning Liu, Shirui Chen, Tao Zhang, Xiuxuan Sun, Ting Guo, Ying Shi, Zheng Zhang, Ding Wei, Peng Lin, Qingyi Wang, Jing Yuan, Jiuxin Qu, Jin Zou, Yingxia Liu, Hongzhou Lu, Ping Zhu, Hui-Jie Bian, Liang Chen
Immunological and metabolic characteristics of the Omicron variants infection. Signal transduction and targeted therapy 8 (1) (2023)
Yue Zhai, Liang Chen, Qian Zhao, Zhao-Hui Zheng, Zhi-Nan Chen, Hui-Jie Bian, Xu Yang, Huan-Yu Lu, Peng Lin, Xi Chen, Ruo Chen, Hao-Yang Sun, Lin-Ni Fan, Kun Zhang, Bin Wang, Xiu-Xuan Sun, Zhuan Feng, Yu-Meng Zhu, Jian-Sheng Zhou, Shi-Rui Chen, Tao Zhang, Si-Yu Chen, Jun-Jie Chen, Kui Zhang, Yan Wang, Yang Chang, Rui Zhang, Bei Zhang, Li-Juan Wang, Xiao-Min Li, Qian He, Xiang-Min Yang, Gang Nan, Rong-Hua Xie, Liu Yang, Jing-Hua Yang, Ping Zhu
Cysteine carboxyethylation generates neoantigens to induce HLA-restricted autoimmunity. Science (New York, N.Y.) 379 (6637) (2023)
Lin He, Hao Li, Can Li, Ze-Kun Liu, Meng Lu, Ren-Yu Zhang, Dong Wu, Ding Wei, Jie Shao, Man Liu, Hao-Lin Wei, Cong Zhang, Zhe Wang, Ling-Min Kong, Zhi-Nan Chen, Hui-Jie Bian
HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression. Cancer communications (London, England) (2023)
Jiejie Geng, Xu Yang, Kun Wang, Ke Wang, Ruo Chen, Zhi-Nan Chen, Chuan Qin, Guizhen Wu, You-Chun Wang, Ke Xu, Peng Du, Jiangning Liu, Shirui Chen, Tao Zhang, Xiuxuan Sun, Ting Guo, Ying Shi, Zheng Zhang, Ding Wei, Peng Lin, Qingyi Wang, Jing Yuan, Jiuxin Qu, Jin Zou, Yingxia Liu, Hongzhou Lu, Ping Zhu, Hui-Jie Bian, Liang Chen
Immunological and metabolic characteristics of the Omicron variants infection. Signal transduction and targeted therapy 8 (1) (2023)
Yue Zhai, Liang Chen, Qian Zhao, Zhao-Hui Zheng, Zhi-Nan Chen, Hui-Jie Bian, Xu Yang, Huan-Yu Lu, Peng Lin, Xi Chen, Ruo Chen, Hao-Yang Sun, Lin-Ni Fan, Kun Zhang, Bin Wang, Xiu-Xuan Sun, Zhuan Feng, Yu-Meng Zhu, Jian-Sheng Zhou, Shi-Rui Chen, Tao Zhang, Si-Yu Chen, Jun-Jie Chen, Kui Zhang, Yan Wang, Yang Chang, Rui Zhang, Bei Zhang, Li-Juan Wang, Xiao-Min Li, Qian He, Xiang-Min Yang, Gang Nan, Rong-Hua Xie, Liu Yang, Jing-Hua Yang, Ping Zhu
Cysteine carboxyethylation generates neoantigens to induce HLA-restricted autoimmunity. Science (New York, N.Y.) 379 (6637) (2023)
Hui-Jie Bian, Liang Chen, Zhao-Hui Zheng, Xiu-Xuan Sun, Jie-Jie Geng, Ruo Chen, Ke Wang, Xu Yang, Shi-Rui Chen, Si-Yu Chen, Rong-Hua Xie, Kui Zhang, Jin-Lin Miao, Jun-Feng Jia, Hao Tang, Shuang-Shuang Liu, Hong-Wei Shi, Yong Yang, Xiao-Chun Chen, Vinay Malhotra, Kulsoom Bano Mehdi, Iffat Khanum, Faisal Mahmood, Saeed Hamid, Claudio Marcel Berdun Stadnik, Kengi Itinose, Caroline Cândida Carvalho de Oliveira, Cesar Dusilek, Lucas Rivabem, Adilson Joaquim Westheimer Cavalcante, Suzara Souto Lopes, Wladmir Faustino Saporito, Fábio José Concilio Fucci, Jesus Abraham Simon-Campos, Ling Wang, Lin-Na Liu, Qing-Yi Wang, Ding Wei, Zheng Zhang, Zhi-Nan Chen, Ping Zhu
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial. Signal transduction and targeted therapy 8 (1) (2023)
Jiao Wu, Liang Chen, Chuan Qin, Fei Huo, Xue Liang, Xu Yang, Kui Zhang, Peng Lin, Jiangning Liu, Zhuan Feng, Jiansheng Zhou, Zhuo Pei, Yatao Wang, Xiu-Xuan Sun, Ke Wang, Jiejie Geng, Zhaohui Zheng, Xianghui Fu, Man Liu, Qingyi Wang, Zheng Zhang, Hui-Jie Bian, Ping Zhu, Zhi-Nan Chen
CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis. Signal transduction and targeted therapy 7 (1) (2022)
Cheng-Gong Liao, Xiao-Hua Liang, Yuan Ke, Li Yao, Man Liu, Ze-Kun Liu, Lin He, Yi-Xiao Guo, Hui-Jie Bian, Zhi-Nan Chen, Ling-Min Kong
Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis. Oncogene 41 (12) (2022)
Hong-Yong Cui, Shi-Jie Wang, Fei Song, Xu Cheng, Gang Nan, Yu Zhao, Mei-Rui Qian, Xi Chen, Jia-Yue Li, Fen-Ling Liu, Yu-Meng Zhu, Ruo-Fei Tian, Bin Wang, Bin Wu, Yang Zhang, Xiu-Xuan Sun, Ting Guo, Xiang-Min Yang, Hai Zhang, Ling Li, Jing Xu, Hui-Jie Bian, Jian-Li Jiang, Zhi-Nan Chen
CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression. Signal transduction and targeted therapy 6 (1) (2021)
Jiejie Geng, Liang Chen, Yufeng Yuan, Ke Wang, You-Chun Wang, Chuan Qin, Guizhen Wu, Ruo Chen, Zheng Zhang, Ding Wei, Peng Du, Jun Zhang, Peng Lin, Kui Zhang, Yong-Qiang Deng, Ke Xu, Jiangning Liu, Xiuxuan Sun, Ting Guo, Xu Yang, Jiao Wu, Jianli Jiang, Ling Li, Kun Zhang, Zhe Wang, Jing Zhang, Qingguo Yan, Hua Zhu, Zhaohui Zheng, Jinlin Miao, Xianghui Fu, Fengfan Yang, Xiaochun Chen, Hao Tang, Yang Zhang, Ying Shi, Yumeng Zhu, Zhuo Pei, Fei Huo, Xue Liang, Yatao Wang, Qingyi Wang, Wen Xie, Yirong Li, Mingyan Shi, Hui-Jie Bian, Ping Zhu, Zhi-Nan Chen
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma. Signal transduction and targeted therapy 6 (1) (2021)
Hui-Jie Bian, Zhao-Hui Zheng, Ding Wei, Aidong Wen, Zheng Zhang, Jian-Qi Lian, Wen-Zhen Kang, Chun-Qiu Hao, Jing Wang, Rong-Hua Xie, Ke Dong, Jie-Lai Xia, Jin-Lin Miao, Wen Kang, Guoquan Li, Di Zhang, Mingru Zhang, Xiu-Xuan Sun, Likun Ding, Kui Zhang, Junfeng Jia, Jin Ding, Zhiqin Li, Yanyan Jia, Lin-Na Liu, Zhe Zhang, Zhao-Wei Gao, Hong Du, Na Yao, Qing Wang, Ke Wang, Jie-Jie Geng, Bin Wang, Ting Guo, Ruo Chen, Yu-Meng Zhu, Li-Juan Wang, Qian He, Rui-Rui Yao, Ying Shi, Xiang-Min Yang, Jian-Sheng Zhou, Yi-Nan Ma, Ya-Tao Wang, Xue Liang, Fei Huo, Zhe Wang, Yang Zhang, Xu Yang, Ye Zhang, Lu-Hua Gao, Ling Wang, Xiao-Chun Chen, Hao Tang, Shuang-Shuang Liu, Qing-Yi Wang, Zhi-Nan Chen, Ping Zhu
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial. Signal transduction and targeted therapy 6 (1) (2021)
Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Ming Kong, Zhi-Nan Chen, Hui-Jie Bian
Hepatic artery injection of 131I-metuximab combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective non-randomized, multicenter clinical trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2021)
Hao Li, Tian Zhang, Ke Wang, Meng Lu, Yonghong Guo, Ye Zhang, Zhi-Nan Chen, Hui-Jie Bian
MFGE8 protects against CCl4 -induced liver injury by reducing apoptosis and promoting proliferation of hepatocytes. Journal of cellular physiology (2019)
Yu-Le Yong, Ren-Yu Zhang, Ze-Kun Liu, Ding Wei, Yu-Kui Shang, Jiao Wu, Zhi-Yun Zhang, Can Li, Zhi-Nan Chen, Hui-Jie Bian
Gamma-secretase complex-dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma. The Journal of pathology 249 (2) (2019)
Dan Luo, Zheng Zhang, Zhao Zhang, Jia-Yue Li, Jian Cui, Wen-Pu Shi, Xi-Wen Dong, Lin Yuan, Peng Lin, Zhi-Nan Chen, Hui-Jie Bian, Zi-Ling Wang
Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A. Journal of immunology research 2018 (2018)
Qian Li, Ding Wei, Fei Feng, Xi-Long Wang, Can Li, Zhi-Nan Chen, Hui-Jie Bian
α2,6-linked sialic acid serves as a high-affinity receptor for cancer oncolytic virotherapy with Newcastle disease virus. Journal of cancer research and clinical oncology 143 (11) (2017)

Hui-Jie Bian.css-eqlu8i{font-size:small;padding-left:4px;} (Huijie Bian)

Publication Activity (10 Years)

Top Topics

Top Venues

Hui-Jie Bian (Huijie Bian)